NCT03662386

Brief Summary

This study will carry out a detailed descriptive analysis of a large population of patients with hereditary retinal dystrophies (HRD): clinical, paraclinical and genetic data. The information drawn from these analyzes will provide a better understanding of the pathophysiology of these rare diseases and this may ultimately impact the medical management of patients (targeted therapy).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 7, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

September 14, 2018

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2025

Completed
Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

6.5 years

First QC Date

August 1, 2018

Last Update Submit

December 3, 2025

Conditions

Keywords

hereditary retinal dystrophies

Outcome Measures

Primary Outcomes (2)

  • Description of the phenotypic characteristics of patients with hereditary retinal dystrophies.

    Phenotypic diagnosis of the type of retinal dystrophy based on all the examinations performed as part of the usual care and examinations added by the research (OCT-Angiography - Optical coherence tomography, and visual acuity with ETDRS scale : Early Treatment Diabetic Retinal Study, ETDRS).

    Baseline

  • Description of the genotypic characteristics of patients with hereditary retinal dystrophies.

    Determination of the genetic mutations responsible for retinal dystrophy in order to confirm the phenotypic diagnosis and identify correlation between the phenotypic and genotypic characteristics

    Baseline

Study Arms (1)

Patients with suspicion of hereditary retinal dystrophy

Procedure: OCT-AProcedure: Visual acuity (ETDRS)

Interventions

OCT-APROCEDURE

Optical coherence tomography angiography (OCT-A)

Patients with suspicion of hereditary retinal dystrophy

Visual acuity tested with ETDRS score (Early Treatment Diabetic Retinopathy Study)

Patients with suspicion of hereditary retinal dystrophy

Eligibility Criteria

Age15 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized for suspicion of hereditary retinal distrophy

You may qualify if:

  • Patients hospitalized for suspicion of hereditary retinal dystrophy
  • Benefiting as part of the care of a genetic analysis

You may not qualify if:

  • \- Patient under a measure of legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation ophtalmologique Adolphe de Rothschild

Paris, 75019, France

Location

MeSH Terms

Interventions

Visual Acuity

Intervention Hierarchy (Ancestors)

Vision TestsDiagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosisOcular Physiological Phenomena

Study Officials

  • Elise BOULANGER SCEMAMA

    Fondation Ophtalmologique A. de Rothschild

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2018

First Posted

September 7, 2018

Study Start

September 14, 2018

Primary Completion

March 14, 2025

Study Completion

March 14, 2025

Last Updated

December 10, 2025

Record last verified: 2025-12

Locations